[Federal Register Volume 74, Number 217 (Thursday, November 12, 2009)]
[Notices]
[Page 58313]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-27180]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 15, 2009, and published in the Federal 
Register on June 23, 2009, (74 FR 29719), Noramco Inc., Division of 
Ortho-McNeil, Inc., 1440 Olympic Drive, Athens, Georgia 30601, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of Tapentadol (9780), a basic 
class of controlled substance listed in schedule II.
    The company plans to bulk manufacture the above listed controlled 
substance for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Noramco, Inc. to manufacture the listed basic classes of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Noramco, Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with State and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. Sec.  823, and in accordance with 21 CFR 1301.33, the 
above named company is granted registration as a bulk manufacturer of 
the basic classes of controlled substances listed.

    Dated: November 3, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-27180 Filed 11-10-09; 8:45 am]
BILLING CODE 4410-09-M